Gail Cawkwell, SVP of Intercept Pharmaceuticals, recently disposed of 319 shares of the company. The disposals took place at $19.04 per share, on November 12, 2021. Cawkwell still owns 31,915 shares of the company. Cawkwell operates out of New York, NY. Some additional info was provided as follows:
Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification wheneve r Intercept Pharmaceuticals makes a similar move, sign up!
Other recent filings from the company include the following:
Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 2,455 shares - Jan. 13, 2022
Departure of Directors or Certain - Jan. 10, 2022
Statement of changes in beneficial ownership of securities - Jan. 4, 2022
SVP of Intercept Pharmaceuticals just disposed of 2,455 shares - Jan. 4, 2022
Intercept Pharmaceuticals's Chief Human Resources Officer just disposed of 1,712 shares - Jan. 4, 2022